Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy-Reference-Cited by-同舟云学术

Immunosuppression with an interleukin-2 fusion protein leads to improved LV function in experimental ischemic cardiomyopathy

Published:2010-02 Issue:2 Volume:10 Page:207-212
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Koch Matthias,Savvatis Konstantinos,Scheeler Michael,Dhayat Sameer,Bonaventura Klaus,Pohl Thomas,Riad Alexander,Bulfone-Paus Silvia,Schultheiss Heinz-Peter,Tschöpe Carsten

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference36 articles.

1. Congestive heart failure: fifty years of progress;Braunwald;Circulation,2000

2. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1;Sharma;Int J Cardiol,2000

3. Cytokines and heart failure;Paulus;Heart Fail Monit,2000

4. Anti-tumour necrosis factor-alpha therapy in heart failure: future directions;Balakumar;Basic Clin Pharmacol Toxicol,2006

5. The role of nitric oxide and cytokines in heart failure;Birks;Coron Artery Dis,1997

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological Effects of Various Interleukins on Primary Cell Types in Common Heart Disease;International Journal of Molecular Sciences;2023-03-30

2. Dilated cardiomyopathy and chronic cardiac inflammation: Pathogenesis, diagnosis and therapy;Journal of Internal Medicine;2022-08-27

3. Virus-Host Interactions of Enteroviruses and Parvovirus B19 in Myocarditis;Cellular Physiology and Biochemistry;2021-11-18

4. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions;Nature Reviews Cardiology;2020-10-12

5. The Quest for Antiinflammatory and Immunomodulatory Strategies in Heart Failure;Clinical Pharmacology & Therapeutics;2019-10-28